Pure Global AI
ANVISA registration 10259610254Valid until Feb 10, 2035

HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)

ANVISA Registration Number: 10259610254MEDIVAX INDÚSTRIA E COMÉRCIO LTDAVIRCELL S.L.Risk Class IV
Verified
Device names
Technical name
HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV)
View exact technical-name matches →
PT: HERPES VÍRUS (HHV 4) - VÍRUS EPSTEIN-BARR (EBV)
Commercial name
EPSTEIN-BARR VCA ELISA IgG
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
10259610254
Process Number
25351361771202405
CNPJ
68814961000173
Company information
Registration Holder
MEDIVAX INDÚSTRIA E COMÉRCIO LTDA
Manufacturer
VIRCELL S.L.
Manufacturing Country
Spain
PT: ESPANHA
Dates and status
Publication Date
Feb 10, 2025
Validity
10/02/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10259610254 and manufactured by VIRCELL S.L.. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until Feb 10, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.